LMND (LMND) Form 144 details $5.59M planned insider stock sale

Rhea-AI Filing Summary

LMND filed a Form 144 notice for a planned sale of common stock under Rule 144. The notice covers 70,794 shares of common stock to be sold through broker Oppenheimer & Co. Inc. on the NYSE, with an aggregate market value of $5,590,602.18. The filing states that 74,731,027 shares of the issuer’s common stock are outstanding. The securities relate to stock acquired through an employee stock option plan and restricted stock units over several years.

The notice also discloses that Adina Eckstein has sold common shares of the issuer during the prior three months, including 40,000 shares on 11/07/2025 for gross proceeds of $2,920,868.00 and 5,988 shares on 11/17/2025 for gross proceeds of $467,064.00. By signing the notice, the seller represents that they are not aware of any material adverse, nonpublic information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	70794	5590602.18	74731027	12/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/07/2020	Employee Stock Option Plan	Issuer			16250	12/08/2025	Cash- Upon Exercise
Common	12/06/2021	Employee Stock Option Plan	Issuer			28125	12/08/2025	Cash- Upon Exercise
Common	12/06/2021	Employee Stock Option Plan	Issuer			2661	12/08/2025	Cash- Upon Exercise
Common	02/16/2021	RSU	Issuer			10000	02/16/2021	N/A
Common	07/21/2021	RSU	Issuer			20000	07/21/2021	N/A
Common	02/07/2023	RSU	Issuer			56252	02/07/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Adina Eckstein 5 Crosby Street 3rd Floor New York NY 10013	Common	11/07/2025	40000	2920868.00
Adina Eckstein 5 Crosby Street 3rd Floor, New York NY 10013	Common	11/17/2025	5988	467064.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the LMND Form 144 filing disclose?

The Form 144 filing discloses a proposed sale of 70,794 shares of LMND common stock to be sold through Oppenheimer & Co. Inc. on the NYSE, with an aggregate market value of $5,590,602.18 at the time of the notice.

How many LMND shares are outstanding according to this Form 144?

The filing states that there are 74,731,027 shares of the issuer’s common stock outstanding.

Who has recently sold LMND shares and in what amounts?

The filing shows that Adina Eckstein sold LMND common stock in the past three months, including 40,000 shares on 11/07/2025 for gross proceeds of $2,920,868.00 and 5,988 shares on 11/17/2025 for gross proceeds of $467,064.00.

How were the LMND shares in this Form 144 acquired?

The shares listed in the notice were acquired through an Employee Stock Option Plan and RSU (restricted stock unit) grants from the issuer on various dates between 2020 and 2023.

What representations does the seller make in the LMND Form 144?

By signing, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, as required under Rule 144.

Which broker is handling the proposed LMND share sale under this Form 144?

The proposed sale of LMND common stock is to be handled by Oppenheimer & Co. Inc., located at 85 Broad St., New York, NY 10004, and the shares are listed for trading on the NYSE.